Related Experiment Videos

Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid

Insights

Micronized 8-methoxypsoralen (8-MOP) showed faster absorption and higher serum levels compared to nonmicronized 8-MOP. Skin sensitization persists longer than serum levels suggest, indicating sustained photosensitization.

Area of Science:

  • Pharmacokinetics
  • Dermatology
  • Photochemotherapy

Background:

  • 8-methoxypsoralen (8-MOP) is a photosensitizer used in photochemotherapy.
  • Drug formulation, such as micronization, can impact pharmacokinetic profiles.
  • Understanding drug absorption and skin retention is crucial for optimizing therapeutic efficacy and safety.

Purpose of the Study:

  • To compare the pharmacokinetic profiles of micronized versus nonmicronized 8-methoxypsoralen (8-MOP).
  • To investigate the relationship between serum 8-MOP levels and skin photosensitization.
  • To determine the impact of particle size on 8-MOP absorption and distribution.

Main Methods:

  • Administration of micronized and nonmicronized 8-MOP to patients.
  • Serial blood sampling to measure serum 8-MOP concentrations.
  • Blister fluid collection to assess drug concentration in the skin.

Main Results:

  • Micronized 8-MOP resulted in significantly higher and more rapid serum level profiles compared to nonmicronized 8-MOP.
  • Peak serum levels of micronized 8-MOP were achieved within 1 hour in 75% of patients.
  • Drug reduction in skin was slower than in serum, suggesting prolonged skin photosensitization.

Conclusions:

  • Micronization enhances the absorption and bioavailability of 8-MOP.
  • Despite decreasing serum levels, skin remains photosensitized for a considerable duration after 8-MOP administration.
  • These findings have implications for optimizing dosing and treatment schedules in photochemotherapy.

Related Concept Videos